rs147444165

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_018718.3(CEP41):​c.1009T>C​(p.Ser337Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000426 in 1,614,066 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0020 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00026 ( 2 hom. )

Consequence

CEP41
NM_018718.3 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 0.151
Variant links:
Genes affected
CEP41 (HGNC:12370): (centrosomal protein 41) This gene encodes a centrosomal and microtubule-binding protein which is predicted to have two coiled-coil domains and a rhodanese domain. In human retinal pigment epithelial cells the protein localized to centrioles and cilia. Mutations in this gene have been associated with Joubert Syndrome 15; an autosomal recessive ciliopathy and neurological disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0067655146).
BP6
Variant 7-130399004-A-G is Benign according to our data. Variant chr7-130399004-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 358939.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00205 (312/152230) while in subpopulation AFR AF= 0.00703 (292/41536). AF 95% confidence interval is 0.00637. There are 1 homozygotes in gnomad4. There are 151 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 2 AR,Digenic gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP41NM_018718.3 linkc.1009T>C p.Ser337Pro missense_variant Exon 11 of 11 ENST00000223208.10 NP_061188.1 Q9BYV8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP41ENST00000223208.10 linkc.1009T>C p.Ser337Pro missense_variant Exon 11 of 11 1 NM_018718.3 ENSP00000223208.4 Q9BYV8-1

Frequencies

GnomAD3 genomes
AF:
0.00202
AC:
307
AN:
152112
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00693
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00144
GnomAD3 exomes
AF:
0.000593
AC:
149
AN:
251110
Hom.:
0
AF XY:
0.000442
AC XY:
60
AN XY:
135750
show subpopulations
Gnomad AFR exome
AF:
0.00634
Gnomad AMR exome
AF:
0.000867
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000969
Gnomad OTH exome
AF:
0.000653
GnomAD4 exome
AF:
0.000257
AC:
375
AN:
1461836
Hom.:
2
Cov.:
31
AF XY:
0.000226
AC XY:
164
AN XY:
727224
show subpopulations
Gnomad4 AFR exome
AF:
0.00759
Gnomad4 AMR exome
AF:
0.000783
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000696
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000207
Gnomad4 OTH exome
AF:
0.000844
GnomAD4 genome
AF:
0.00205
AC:
312
AN:
152230
Hom.:
1
Cov.:
32
AF XY:
0.00203
AC XY:
151
AN XY:
74432
show subpopulations
Gnomad4 AFR
AF:
0.00703
Gnomad4 AMR
AF:
0.000850
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000441
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.000459
Hom.:
1
Bravo
AF:
0.00244
ESP6500AA
AF:
0.00635
AC:
28
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000717
AC:
87
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.000296

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Oct 10, 2019
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 18, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

CEP41: BP4, BS2 -

Joubert syndrome 15 Benign:2
Jan 09, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

CEP41-related disorder Benign:1
Nov 05, 2021
PreventionGenetics, part of Exact Sciences
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.043
.;T;.
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.24
FATHMM_MKL
Benign
0.36
N
LIST_S2
Benign
0.80
T;T;T
M_CAP
Benign
0.077
D
MetaRNN
Benign
0.0068
T;T;T
MetaSVM
Benign
-0.34
T
MutationAssessor
Uncertain
2.0
.;M;.
PrimateAI
Benign
0.35
T
PROVEAN
Benign
-0.25
N;N;N
REVEL
Benign
0.26
Sift
Benign
0.22
T;D;T
Sift4G
Benign
0.24
T;T;T
Polyphen
0.68, 0.53
.;P;P
Vest4
0.11
MVP
0.83
MPC
0.23
ClinPred
0.040
T
GERP RS
-1.6
Varity_R
0.13
gMVP
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs147444165; hg19: chr7-130038845; API